President Trump has been all over this for well over a week. He had the sagacity to send massive quantities of the drugs hydroxychloroquine and zithromax to the epicenter of coronavirus, New York.
The media will never report of this. Good news and hope are verboten.
Belgium joins Bahrain in affirming coronavirus treatment touted by Trump is working for patients. It is ordering doctors to preserve the hydroxychloroquine pills for COVID-19 patients most in need. https://t.co/yu4bG2mlOR
— John Solomon (@jsolomonReports) March 26, 2020
Bahrain, Belgium report coronavirus treatment touted by Trump is working for patients
Clinical Tests of Hydroxychloroquines to Fight COVID-19 in Bahrain prove successful
By Just the News, March 26, 2020:
Bahrain and Belgium report their hospitals are successfully treating coronavirus patients with the anti-malaria drug hydroxychloroquine touted by President Trump as a possible breakthrough in the pandemic.
The Kingdom of Bahrain’s Supreme Council of Health chairman said his country was among the first to use the drug and that its impact has been “profound,” according to the Bahrain News Agency.
Dr. Shaikh Mohamed, who leads the National Taskforce for Combating COVID-19, was also quoted by the news agency as saying hydroxychloroquine was administered according to the same regimens as those used in China and South Korea.
The first COVID-19 case in Bahrain was reported on Feb. 21, and hydroxychloroquine was first administered to patients showing virus symptoms on Feb. 26. As of March 25, the virus had caused 4 deaths in Bahrain, according to the Johns Hopkins Coronavirus Resource Center.
Hydroxychloroquine is used to prevent and treat malaria and is administered to patients with rheumatoid arthritis or lupus.
Meanwhile in Europe, another U.S. ally, Brussels, is reporting similar early success with the same drug and is taking steps to ensure its availability for the sickest coronavirus patients.
“Using the limited stocks of these medicines for unnecessary or unjustified preventive treatments jeopardizes the availability of these medicines for patients who need them: chronic patients and hospital patients seriously affected by Covid-19,” Belgium’s Federal Agency for Medicines and Health Products said this week.
Belgium, like the United States, has begun a longer-term clinical trial on the efficacy of using Hydroxychloroquine to treat COVID-19 patients.
Have a tip we should know? Your anonymity is NEVER compromised. Email firstname.lastname@example.org
The Truth Must be Told
Your contribution supports independent journalism
Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.
Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.
Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.
Please contribute here.
Make a monthly commitment to support The Geller Report – choose the option that suits you best.